naion glp 1 Australian regulator warns of 'rare but severe' eye disorder linked to GLP-1 drugs like Ozempic | Health MHRA-publishes-updated-GLP-1-guidance-due-to-NAION-risk

doi: 10.1002/brb3.1726

AFL General Counsel Andrew Dillon said on Wednesday ASADA's advice was consistent with a WADA statement in April

These class actions allege that the drug makers engaged in misleading marketing campaigns, failed to provide adequate warnings, and ignored growing concerns raised in medical literature and post-marketing surveillance about serious side effects, including gastrointestinal disorders, cyclic vomiting syndrome, and sudden vision loss

The Marketing Tightrope: Speak to Everyone, Not Just the Medicine Cabinet Here's the tricky part: you want to capture GLP-1 users without alienating everyone else

At Cymbiotika, we are committed to providing you with high-quality, science-backed supplements that support your overall wellness